Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. MYO
MYO logo

MYO Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Myomo Inc (MYO) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Sell
Latest Price
1.160
1 Day change
0.87%
52 Week Range
2.400
Analysis Updated At
2026/07/03
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Myomo Inc is not a good buy right now for a Beginner long-term investor with $50,000-$100,000 to deploy. The stock is trading weakly near support, lacks a bullish proprietary signal, has no recent news catalyst, and the options setup is extremely speculative rather than confirming healthy demand. Based on the data provided, I would avoid buying now and wait for a clearer turnaround.

Technical Analysis

MYO is in a weak short-term downtrend. Price closed at 1.02, slightly below the previous close of 1.03, with the market also weak. MACD histogram is negative at -0.0457 and still below zero, which confirms bearish momentum, though it is contracting. RSI_6 at 34.184 is neutral but close to oversold territory, suggesting weakness without a strong reversal signal. Moving averages are converging, which often means a decision point is near, but the stock is currently hovering just above S1 at 1.011 and below the pivot at 1.198, so the technical setup is not favorable for an immediate long-term entry. The similar-candlestick model also points to modest near-term downside risk.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Trading sentiment from options is very bullish on paper, but the data looks thin and highly speculative. Open interest put-call ratio of 0.05 and volume put-call ratio of 0.0 indicate calls dominate puts sharply. However, total today’s volume is only 7 contracts, which is too low to treat this as strong conviction. Implied volatility is extremely elevated at 650.98 with IV percentile 99.6 and IV rank 81.17, which signals very expensive options and high speculation rather than stable directional confidence. Net: bullish skew, but low-quality confirmation.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
4
Buy
5

Positive Catalysts

  • ["Insiders are buying, with buying amount up 1251.40% over the last month.", "Options positioning is strongly call-skewed, which can reflect speculative bullish sentiment.", "Price is near a support zone around 1.011, so a technical bounce is possible."]

Neutral/Negative Catalysts

  • ["No news in the recent week, so there is no fresh catalyst driving demand.", "MACD remains negative and price is below the pivot level.", "Historical pattern analysis suggests a 60% chance of further short-term downside.", "Hedge funds are neutral with no significant trading trend over the last quarter.", "No recent congress trading data and no politician/influencer buys or sells were reported.", "Options activity is extremely low in actual volume, making the bullish skew less reliable."]

Financial Performance

No usable financial snapshot was available because of an error, so the latest quarter financials and growth trends cannot be assessed from the provided data. That means there is no confirmed fundamental support for a long-term buy decision in this case.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target trend data was provided, so there is no visible Wall Street upgrade/downgrade or target revision trend to support the stock. Based on the available information, Wall Street sentiment cannot be described as bullish; the pros view is limited to insider buying and call-heavy options flow, while the cons view is weak momentum, no news catalyst, and no fundamental confirmation.

Wall Street analysts forecast MYO stock price to rise
5 Analyst Rating
Wall Street analysts forecast MYO stock price to rise
5 Buy
0 Hold
0 Sell
Strong Buy
Current: 1.150
sliders
Low
4
Averages
5.75
High
10
Current: 1.150
sliders
Low
4
Averages
5.75
High
10
Alliance Global
Buy
downgrade
$4 -> $3
AI Analysis
2026-03-12
Reason
Alliance Global
Price Target
$4 -> $3
AI Analysis
2026-03-12
downgrade
Buy
Reason
Alliance Global lowered the firm's price target on Myomo to $3 from $4 and keeps a Buy rating on the shares following the Q4 report. The firm cites its lower forecasts and a reduced multiple of sales for the target cut.
H.C. Wainwright
H.C. Wainwright
Buy
downgrade
$5
2025-08-12
Reason
H.C. Wainwright
H.C. Wainwright
Price Target
$5
2025-08-12
downgrade
Buy
Reason
H.C. Wainwright lowered the firm's price target on Myomo to $5 from $9.50 and keeps a Buy rating on the shares. The firm says that while the company's Q2 ended well, there are warning signs ahead as Myomo reported that the number of patients added to its pipeline was significantly lower than expected.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for MYO
Unlock Now

People Also Watch